Compare Quest Diagnostics Inc (DGX) vs S&P Global Inc (SPGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs S&P Global Inc — how do they compare? Quest Diagnostics Inc trades at $204.59 (market cap $22.80B), while S&P Global Inc trades at $448.57 (market cap $129.91B). The key difference: S&P Global Inc is far larger — about 5.7× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays the higher dividend (1.67%). Which is the better fit depends on your goals.
| DGX | SPGI | |
|---|---|---|
Market Cap | $22.80B | $129.91B |
Sector | Health | Financials |
52-Week High | $216.02 | $534.79 |
52-Week Low | $166.42 | $370.42 |
Enterprise Value | $28.82B | $141.87B |
Dividend Yield | 1.67% | 0.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
S&P Global (SPGI) trades at $437.84, up 1.7% today, with a bullish technical outlook and strong analyst consensus. The stock shows robust fundamentals with 2025 revenue of $15.34B and net income margin of 30.36%. Recent developments include the completion of the Mobility Global spinoff and a strategic shift toward AI-driven market intelligence solutions, positioning the company for sustained growth amid favorable debt issuance trends.
The outlook for SPGI is positive, driven by margin expansion targets and increasing API usage linked to AI adoption. Key risks include interest rate sensitivity in the ratings segment and competitive pressures. With 85.7% of analysts rating it a Buy and a consensus price target of $532.38, the stock offers significant upside potential, though investors should monitor execution on growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About S&P Global Inc
S&P Global provides data and benchmarks to capital and commodity market participants. In 2021 and excluding IHS Markit, S&P Ratings was over 45% of the firm's revenue and over 55% of the firm's operating income. S&P Ratings is the largest credit rating agency in the world. The firm's other segments include Market Intelligence, Indices, and Platts. Market Intelligence provides desktop tools and other data solutions to investment banks, corporations, and other entities. Indices provides benchmarks for financial markets and is monetized through subscriptions, asset-based fees, and transaction-based royalties. Platts provides benchmarks to commodity markets, principally petroleum.
Read more on SPGI →
